$18.98
-0.59 (-3.01%)
Open$19.31
Previous Close$19.57
Day High$20.99
Day Low$18.76
52W High$29.16
52W Low$0.00
Volume—
Avg Volume262.8K
Market Cap904.4K
P/E Ratio—
EPS$-1.42
SectorBiotechnology
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 14.6K | 9.1K | 130.17M |
| Net Income | -89,830 | -50,362 | -10,475,587 |
| Profit Margin | -613.3% | -582.6% | -8.1% |
| EBITDA | -82,692 | -48,936 | -16,170,256 |
| Free Cash Flow | — | — | -10,179,409 |
| Rev Growth | +60.5% | +60.5% | -3.3% |
| Debt/Equity | 0.51 | 0.51 | 0.07 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |